“…Notably, despite the increasing use of hypo-fractionated or stereotactic ablative RT, known to improve IR’s ability to promote immune responses to tumors [ 4 ], AE has remained a rare phenomenon for a long time, with only 46 cases reported up to 2014 [ 5 ]. However, the introduction of immune checkpoint inhibitors (ICIs), shown to boost the RT-induced immune response [ 6 , 7 ] and to be potentiated by RT [ 8 ], has drastically increased the number of cases reporting AE [ 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , …”